Literature DB >> 35015217

Screening the Efficacy of Melatonin on Neurodegeneration Mediated by Endoplasmic Reticulum Stress, Inflammation, and Oxidative Damage.

Fathima Hajee Basha1.   

Abstract

Neurodegeneration may be defined as a clinical condition wherein neurons gradually lose their structural integrity, viability, and functional abilities and the damage inflicted upon the neurons is often irreversible. The various mechanisms that have been observed to contribute to neurodegeneration include aggregation and accumulation of misfolded proteins, impaired autophagy, oxidative damage, neuroinflammation, mitochondrial defects, increased SUMOylation of proteins, impaired unfolded protein response (UPR) pathways, and disruption of axonal transport. Melatonin, a neurohormone, is involved in a variety of functions including scavenging free radicals, synchronizing the circadian rhythm, and mitigating immune response. Melatonin has shown to modulate the UPR pathway, antioxidant pathway through Nrf2 and inflammatory pathway through NFκB. The study aims to determine the efficacy of melatonin on neurodegeneration mediated by endoplasmic reticulum (ER) stress, inflammation, and oxidative damage through in silico approaches. The molecular targets chosen were ATF6, XBP1, PERK, Nrf2, and NFκB and they were docked against melatonin. Melatonin showed to have binding energy with ATF6 as - 4.8 kJ, with PERK as - 3.2 kJ, with XBP1 as - 4.8 kJ, with Nrf2 as - 4.5 kJ, and with that of NFκB as - 4.2 kJ, which implies it interacts well with them. Additionally various physiochemical analyses such as absorption, distribution, metabolism, excretion (ADME) were also carried out. Those analyses revealed that it has an optimal log P of about 1.98, optimal log S of - 2.34, is BBB permeant, has high GI absorption, is not a P-Gp substrate, has a TPSA of 54.12, has a molecular weight of 232.28, and has about 4 rotatable bonds. Also, it showed a bioactivity score of 0.06 for GPCR which implies that it is most likely to exert its function by binding GPCR. The findings imply that melatonin not only shows excellent interactions with the targets but also possesses drug-like physicochemical properties that makes it a valuable choice for the treatment of neurodegenerative disorders.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Antioxidant; ER stress; In silico; Inflammation; Melatonin; Neurodegeneration

Mesh:

Year:  2022        PMID: 35015217     DOI: 10.1007/s12010-022-03814-x

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  26 in total

Review 1.  ER stress and the unfolded protein response in neurodegeneration.

Authors:  Claudio Hetz; Smita Saxena
Journal:  Nat Rev Neurol       Date:  2017-07-21       Impact factor: 42.937

Review 2.  The role of endoplasmic reticulum stress in neurodegenerative disease.

Authors:  Chunchen Xiang; Yujia Wang; Han Zhang; Fang Han
Journal:  Apoptosis       Date:  2017-01       Impact factor: 4.677

Review 3.  Significance of brain tissue oxygenation and the arachidonic acid cascade in stroke.

Authors:  Cameron Rink; Savita Khanna
Journal:  Antioxid Redox Signal       Date:  2010-12-04       Impact factor: 8.401

Review 4.  Melatonin as a potential modulator of Nrf2.

Authors:  Zahra Ahmadi; Milad Ashrafizadeh
Journal:  Fundam Clin Pharmacol       Date:  2019-07-31       Impact factor: 2.748

Review 5.  Cellular and molecular mechanism in neurodegeneration: Possible role of neuroprotectants.

Authors:  Fathima Hajee Basha; Mohammad Waseem; Hemalatha Srinivasan
Journal:  Cell Biochem Funct       Date:  2021-03-01       Impact factor: 3.685

Review 6.  Melatonin and endoplasmic reticulum stress: relation to autophagy and apoptosis.

Authors:  Anna Fernández; Raquel Ordóñez; Russel J Reiter; Javier González-Gallego; José L Mauriz
Journal:  J Pineal Res       Date:  2015-08-09       Impact factor: 13.007

Review 7.  Mitophagy and Neuroprotection.

Authors:  Guofeng Lou; Konstantinos Palikaras; Sofie Lautrup; Morten Scheibye-Knudsen; Nektarios Tavernarakis; Evandro F Fang
Journal:  Trends Mol Med       Date:  2019-07-30       Impact factor: 11.951

Review 8.  The neuroprotective role of melatonin in neurological disorders.

Authors:  B S Alghamdi
Journal:  J Neurosci Res       Date:  2018-03-01       Impact factor: 4.164

Review 9.  The unfolded protein response in neurodegenerative diseases: a neuropathological perspective.

Authors:  Wiep Scheper; Jeroen J M Hoozemans
Journal:  Acta Neuropathol       Date:  2015-07-26       Impact factor: 17.088

Review 10.  Basic mechanisms of neurodegeneration: a critical update.

Authors:  Kurt A Jellinger
Journal:  J Cell Mol Med       Date:  2010-01-11       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.